SOPHiA GENETICS (SOPH) Cash from Discontinued Operations (2021 - 2025)

SOPHiA GENETICS (SOPH) reported Cash from Discontinued Operations of 10750000.0 for Q1 2025, up 26.6% on a YoY basis from 8491572.28 in Q1 2024, and up 26.6% sequentially from 14645000.0 in Q1 2024.

SOPHiA GENETICS (SOPH) Cash from Discontinued Operations (2021 - 2025) Analysis & Trends

SOPHiA GENETICS (SOPH) has 5 years of Cash from Discontinued Operations data on file, last reported at 10750000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Discontinued Operations (Qtr)
1 Veeva Systems 31.76 Bn 24.44 Bn 662.02 Mn -
2 BrightSpring Health Services 14.62 Bn 13.72 Bn 482.22 Mn -
3 Healthequity 8.33 Bn 8.06 Bn 256.31 Mn -
4 Hinge Health 5.94 Bn 5.63 Bn 154.23 Mn -
5 10x Genomics 5.81 Bn 5.27 Bn 106.18 Mn -
6 MiniMed 4.52 Bn 4.22 Bn 480.00 Mn -
7 Waystar Holding 4.46 Bn 4.40 Bn 216.84 Mn -
8 Doximity 3.96 Bn 3.21 Bn 125.97 Mn -
9 Privia Health 3.17 Bn 2.75 Bn - -
10 SOPHiA GENETICS 381.60 Mn 311.31 Mn 14.69 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2025 -10.75 Mn
Mar 31, 2025 -10.75 Mn
Mar 31, 2024 -14.65 Mn
Mar 31, 2024 -14.65 Mn
Mar 31, 2023 -14.79 Mn
Mar 31, 2023 -14.79 Mn
Sep 30, 2022 -22.82 Mn
Sep 30, 2022 -22.82 Mn
Jun 30, 2022 -19.55 Mn
Jun 30, 2022 -19.55 Mn
Mar 31, 2022 -17.40 Mn
Mar 31, 2022 -17.40 Mn
Sep 30, 2021 -16.18 Mn
Sep 30, 2021 -16.18 Mn
Jun 30, 2021 -16.22 Mn
Jun 30, 2021 -16.22 Mn
Mar 31, 2021 -10.12 Mn
Mar 31, 2021 -10.12 Mn